Invesco’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,825
| Closed | -$54K | – | 4147 |
|
|
2022
Q1 | $54K | Sell |
2,825
-3
| -0.1% | -$47 | ﹤0.01% | 3924 |
|
|
2021
Q4 | $51K | Sell |
2,828
-860
| -23% | -$25.8K | ﹤0.01% | 3979 |
|
|
2021
Q3 | $136K | Buy |
3,688
+638
| +21% | +$28.3K | ﹤0.01% | 3886 |
|
|
2021
Q2 | $181K | Buy |
3,050
+1,621
| +113% | +$98.2K | ﹤0.01% | 3811 |
|
|
2021
Q1 | $96K | Buy |
1,429
+421
| +42% | +$33K | ﹤0.01% | 3764 |
|
|
2020
Q4 | $61K | Buy |
1,008
+717
| +246% | +$49K | ﹤0.01% | 3720 |
|
|
2020
Q3 | $23K | Buy |
291
+10
| +4% | +$797 | ﹤0.01% | 3616 |
|
|
2020
Q2 | $17K | Sell |
281
-599
| -68% | -$34.9K | ﹤0.01% | 3631 |
|
|
2020
Q1 | $47K | Sell |
880
-37,557
| -98% | -$3.72M | ﹤0.01% | 3611 |
|
|
2019
Q4 | $4.65M | Sell |
38,437
-5,032
| -12% | -$724K | ﹤0.01% | 2206 |
|
|
2019
Q3 | $7.89M | Buy |
43,469
+364
| +0.8% | +$51.3K | ﹤0.01% | 1851 |
|
|
2019
Q2 | $5.6M | Buy |
43,105
+41,790
| +3,178% | +$7.49M | ﹤0.01% | 2108 |
|
|
2019
Q1 | $320K | Buy |
1,315
+107
| +9% | +$28.3K | ﹤0.01% | 3466 |
|
|
2018
Q4 | $230K | Sell |
1,208
-239
| -17% | -$58.3K | ﹤0.01% | 3525 |
|
|
2018
Q3 | $474K | Buy |
1,447
+368
| +34% | +$113K | ﹤0.01% | 3451 |
|
|
2018
Q2 | $337K | Buy |
1,079
+229
| +27% | +$70K | ﹤0.01% | 3563 |
|
|
2018
Q1 | $207K | Buy |
850
+99
| +13% | +$27.8K | ﹤0.01% | 3590 |
|
|
2017
Q4 | $227K | Buy |
751
+5
| +0.7% | +$1.39K | ﹤0.01% | 3511 |
|
|
2017
Q3 | $197K | Buy |
746
+27
| +4% | +$7.81K | ﹤0.01% | 3555 |
|
|
2017
Q2 | $189K | Buy |
+719
| New | +$180K | ﹤0.01% | 3594 |
|
|
2016
Q4 | – | Sell |
-4,483
| Closed | -$1.53M | – | 3709 |
|
|
2016
Q3 | $1.53M | Buy |
+4,483
| New | +$1.64M | ﹤0.01% | 2719 |
|
|
2016
Q2 | – | Sell |
-4,302
| Closed | -$1.38M | – | 3720 |
|
|
2016
Q1 | $1.38M | Buy |
4,302
+4,074
| +1,787% | +$1.39M | ﹤0.01% | 2712 |
|
|
2015
Q4 | $118K | Buy |
228
+1
| +0.4% | +$369 | ﹤0.01% | 3642 |
|
|
2015
Q3 | $66K | Sell |
227
-8
| -3% | -$2.84K | ﹤0.01% | 3713 |
|
|
2015
Q2 | $92K | Buy |
+235
| New | +$82.9K | ﹤0.01% | 3871 |
|
|
2014
Q2 | – | Sell |
-7,929
| Closed | -$2.5M | – | 4090 |
|
|
2014
Q1 | $2.5M | Buy |
+7,929
| New | +$2.52M | ﹤0.01% | 2422 |
|
Other funds holding TXMD
RCMNY
E
GF
Invesco's TXMD Position: Q2 2022 in Review
Invesco sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 2,825 shares — an estimated $54K sold.
Invesco first reported a position in TXMD in Q1 2014 and held it in 26 quarters. The position peaked at $7.89M in Q3 2019. 52 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.
- Invesco reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
- Invesco sold 2,825 TherapeuticsMD shares in Q2 2022, an estimated $54K.
- Invesco first reported a position in TherapeuticsMD in Q1 2014 and held it in 26 quarters.
- Invesco's TherapeuticsMD position peaked at $7.89M in Q3 2019.
- 52 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.
Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.